Triple
T875368
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Advance Market Commitment for pneumococcal vaccines |
E18906
|
entity |
| Predicate | hasTargetDisease |
P20980
|
FINISHED |
| Object | pneumococcal disease |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: pneumococcal disease | Statement: [Advance Market Commitment for pneumococcal vaccines, hasTargetDisease, pneumococcal disease]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasTargetDisease Context triple: [Advance Market Commitment for pneumococcal vaccines, hasTargetDisease, pneumococcal disease]
-
A.
diseaseType
Indicates that one entity is classified as a specific type or category of disease in relation to another entity.
-
B.
diagnosedWith
Indicates that a subject has been identified, typically by a medical professional, as having a particular disease or medical condition.
-
C.
mayBeComorbidWith
Indicates that two conditions or disorders can occur together in the same individual, potentially influencing each other’s presence or severity.
-
D.
diseaseResistance
Indicates how effectively one entity can prevent, withstand, or recover from harmful effects caused by a particular disease or pathogen in relation to another.
-
E.
hasNotableDrug
Indicates that an entity is associated with a drug that is considered notable or significant in some recognized context.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a4938db1f081909bcd1ad2713b6096 |
completed | March 1, 2026, 7:29 p.m. |
| NER | Named-entity recognition | batch_69a4acae12948190923d31966c26a130 |
completed | March 1, 2026, 9:16 p.m. |
| PD | Predicate disambiguation | batch_69a4aa8d47c081909b02a53e305ccf7a |
completed | March 1, 2026, 9:07 p.m. |
| PDg | Predicate description generation | batch_69a4ab9634948190b25ea1b2e34df87d |
completed | March 1, 2026, 9:11 p.m. |
Created at: March 1, 2026, 7:39 p.m.